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The antimicrobial effects of aqueous garlic extracts are well established but those of garlic oil (GO) are little
known. Methodologies for estimating the antimicrobial activity of GO were assessed and GO, GO sulfide
constituents, and garlic powder (GP) were compared in tests against human enteric bacteria. Test methodol-
ogies were identified as capable of producing underestimates of GO activity. Antimicrobial activity was greater
in media lacking tryptone or cysteine, suggesting that, as for allicin, GO effects may involve sulfhydryl
reactivity. All bacteria tested, which included both gram-negative and -positive bacteria and pathogenic forms,
were susceptible to garlic materials. On a weight-of-product basis, 24 h MICs for GO (0.02 to 5.5 mg/ml, 62
enteric isolates) and dimethyl trisulfide (0.02 to 0.31 mg/ml, 6 enteric isolates) were lower than those for a
mixture of diallyl sulfides (0.63 to 25 mg/ml, 6 enteric isolates) and for GP, which also exhibited a smaller MIC
range (6.25 to 12.5 mg/ml, 29 enteric isolates). Viability time studies of GO and GP against Enterobacter
aerogenes showed time- and dose-dependent effects. Based upon its thiosulfinate content, GP was more active
than GO against most bacteria, although some properties of GO are identified as offering greater therapeutic
potential. Further exploration of the potential of GP and GO in enteric disease control appears warranted.
Garlic (Allium sativum) has traditional dietary and medicinal
applications as an anti-infective agent (11, 17). In vitro evi-
dence of the antimicrobial activity of fresh and freeze-dried
garlic extracts against many bacteria (5, 16), fungi (1), and
viruses (20) supports these applications.
Early steps involved in identifying the active constituents of
garlic were the discovery that the compound allicin (allyl 2-pro-
pene thiosulfinate) is formed when garlic cloves are crushed (5,
6, 7) and that its formation depends upon the action of the
enzyme alliinase of the bundle sheath cells upon the alliin of
mesophyll cells (19). Methyl and allyl sulfide derivatives of
allicin are formed by the steam distillation of mashed garlic
(13) to produce garlic oil (GO), which is used in many medic-
inal garlic products.
The classic studies of Cavallito and coworkers (5, 6, 7)
attributed the antibacterial properties of garlic clove ho-
mogenates to allicin. These properties were confirmed against
Escherichia coli and Staphylococcus aureus for garlic clove ho-
mogenates plus related garlic compounds and commercial sup-
plements (9). In Cavallito’s studies, antimicrobial activity was
found neither with aqueous garlic extracts lacking allicin nor
following the addition of GO or diallyl sulfides (5) and no allyl
sulfides were found in freshly prepared aqueous garlic clove
extracts (6). Also, an early gas chromatographic study (4) in-
dicated that the relatively rapid decomposition of allicin
present in aqueous garlic extracts (14) involved transformation
mainly to diallyl sulfides. For these reasons it was concluded
that GO and its constituent sulfides lack antimicrobial activity.
However, high-performance liquid chromatography (HPLC)
applied to aqueous garlic extracts stored at room tempera-
ture for 24 h revealed that allicin transformation (14) was
not to sulfides. Also, the use of agar plate methods (5),
which provide free exposure of garlic compounds to the air
and require good water solubility of test substances, might
explain why antimicrobial activity was not detected for GO,
which is both volatile and hydrophobic. The early conclusion
that GO is not antimicrobial was influential, and investigations
of the antimicrobial properties of GO and its sulfides have
been few (1, 8). GO volatilization losses were avoided in a
recent study (15) which revealed that GO and its major diallyl
sulfides, as well as aqueous garlic extract (reconstituted freeze-
dried garlic powder [GP]) and its major thiosulfinate product,
allicin, each possess significant activity against Helicobacter py-
lori. The MIC of GO was found to lie between those of the
most abundant GO constituents, diallyl disulfide (DADS)
and diallyl trisulfide (DATS). Comparable findings for S.
aureus and E. coli (17) also suggested that GO and GO
sulfides have considerable antibacterial potency. Methyl sul-
fides of GO have not previously been studied.
The influence of test environments upon the activity of an-
timicrobial agents is well-recognized (3, 10), but possible in-
fluences of different culture media upon the antimicrobial ac-
tivities of garlic components are little investigated. It is known
that allicin reacts with cysteine (13) as do major diallyl sulfides
of GO (DADS and DATS but not diallyl sulfide [DAS]) under
simulated physiological conditions (13). Such reactions have
potential importance for the interpretation of in vitro tests
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involving peptone-rich growth media and for the antimicrobial
activity of garlic components in the gut.
In summary, the methodology of early experiments might
explain the negative antimicrobial reputation of GO, while
more recent findings indicate substantial activity against the
few bacterial species that have been tested. Reevaluation of
early methods and of the antibacterial properties of GO and
GO sulfides with appropriate methodologies is therefore mer-
ited. The increasing incidence of bacterial food poisoning and
evidence for considerable sensitivity of H. pylori to GO (15)
indicated enteric bacteria as a suitable subject for this reeval-
uation.
The main objectives of this study were, therefore, to examine
the influences of test environment on antimicrobial activities of
GO and evaluate these activities upon a wide range of enteric
bacteria, including pathogens. Additional objectives were com-
parison of antimicrobial activities of GO and GP upon enteric
bacteria and assessment of the antimicrobial effects of diallyl
and methyl sulfides of GO.
GO and GP were supplied and stored as before (15). A mixture
of diallyl sulfides (supplied as DADS and named DASS) was
obtained from Fluka Chemicals (Gillingham, United Kingdom).
Dimethyl trisulfide (DMT) and dimethyl disulfide (DMD) were
obtained from Pfaltz & Bauer (Waterbury, Conn.).
Garlic components were analyzed by HPLC analysis with
established methods (12, 14) using an LKB Bromma HPLC
System with a 2152 Controller, 2150 HPLC Pump, 2158 UVI-
CORD SD (set at 254 nm), and a 2220 Recording Integrator.
Separations were achieved using a Spherisorb ODS-2 column
with previously described methods (15).
The compositions of GO and GP were similar to those of
samples utilized previously (15). DMT was 99% pure and
DASS included diallyl polysulfides at levels (33% DADS,
16.5% DATS, and 17.5% diallyl tetrasulfide [DATTS], balance
DAS) broadly comparable to those of GO.
Cultures were from the University of Wolverhampton mi-
crobiological culture collection (mainly NCTC or NCIMB
strains) or, in the case of clinical enteric isolates, from local
hospitals (Queen Elizabeth Hospital, Birmingham, United
Kingdom; West Park Hospital, Wolverhampton, United King-
dom). Confirmatory identification procedures were routinely
applied to the latter. Freeze-dried cell cultures were revived by
culture onto suitable agar media. Lactobacillus acidophilus was
routinely cultured on Mann Rogosa Sharpe Agar (MRSA)
(Oxoid, Basingstoke, United Kingdom). Campylobacter Selec-
tive Agar (CSA) (Oxoid) was used for Campylobacter spp., and
all other bacteria were cultured on Tryptone Soya Agar (TSA)
(Difco, BD Biosciences, Franklin Lakes, N.J.). L. acidophilus
and Bacteroides fragilis were incubated at 37°C for 48 h in an
anaerobic cabinet (Forma Scientific, Marietta, Ohio) under
anaerobic conditions (10% H2, 10% CO2, 80% N2). Campy-
lobacter spp. were incubated at 37°C for 48 h under microaero-
philic conditions generated using Oxoid CampyGen sachets in
gas jars (Oxoid). All other bacteria were incubated at 37°C for
24 to 48 h, under aerobic conditions. Broth cultures were
prepared by inoculating the respective liquid growth medium
Mann Rogosa Sharpe broth (MRSB) (Oxoid) or Tryptone
Soya broth (TSB) (Difco) and incubated at 37°C for 24 to 48 h
under appropriate conditions.
Enumeration of viable cells was achieved by serial 10-fold
dilutions in 1/4-strength Ringers solution (Oxoid) and spread-
plating of 0.1 ml of diluted samples onto the appropriate agar
medium. Colonies were counted after incubation for 24 to 48 h
at 37°C.
TSA (Difco) plates used in antimicrobial assays poured to a
depth of approximately 7 mm were surface inoculated by
spreading 0.1 ml of culture over their surface and were allowed
to air dry before storage at 4°C for 1 h. All tests using TSA
plates involved incubation at 37°C for 48 h. Implementation of
the agar radial-diffusion technique involved adding neat GO or
GO diluted and emulsified in TSB to pre-cut 4-mm-diameter
wells. Where direct contact of GO with the bacterial lawn
occurred, bacterial growth was inhibited but no measurable
zones of inhibition of growth for the several species of enteric
bacteria tested (data not shown) were obtained. These results
indicated that studies relying upon diffusion in agar were un-
suitable for testing GO, presumably because of its hydrophobic
nature. When a bacterial lawn was inverted over a 100-ml drop
of undiluted GO placed inside the lid of a glass petri dish,
growth inhibition was observed on the part of the lawn imme-
diately adjacent to the GO, which apparently resulted from air
diffusion of GO vapor. This indicated both antimicrobial ac-
tivity by GO and likely underestimation of such activity in agar
plate studies because of volatilization loss.
A 10% (wt/vol) GO suspension in TSB formed by shaking
was initially homogeneous, but upon standing, GO (density 5
1.037 g/ml) coalesced at the bottom of the vessel within 20 min.
The clear upper fraction obtained failed in MIC tests against
Enterobacter aerogenes. In contrast, samples collected from the
turbid lower fraction yielded a MIC of 0.68 mg/ml, comparable
to that of homogeneous 10% (wt/vol) GO suspensions sampled
immediately after shaking.
To assist dispersal of GO, detergents were incorporated into
the TSB medium, and MICs against E. aerogenes were deter-
mined. Dimethyl sulfoxide, dimethyl formamide, Tween 80,
Triton X-100, and bile salts (Sigma-Aldrich Company Ltd,
Poole, United Kingdom) at concentrations below their MICs
(25% [vol/vol], 12.5% [vol/vol], 25% [vol/vol], 25% [vol/vol],
12.5% [vol/vol], respectively) all produced significant dispersal
of GO. However, no influence upon MICs was observed, so
detergents were not routinely used.
To produce a homogeneous emulsion without detergent,
sterile GO, or GO sulfides, were first diluted 50-fold as 0.5 ml
was added into 9.5 ml of the appropriate broth in a 25-ml
Universal bottle. The bottle was tightly sealed, and the mixture
was shaken vigorously for 3 min just before use.
In tests of incubation conditions, lower MICs and higher
sulfide values were observed at 24 h (data not shown) under
static conditions than those observed after shaking. Under
static conditions, MICs did not differ when metal caps were
compared with tight-sealing ground glass stoppers. Therefore,
static incubation of broths was utilized routinely to minimize
volatilization, and tubes with metal caps were used for conve-
nience and low cost and to ensure a gaseous environment
suitable for microbial growth.
MICs were determined by incubation at 37°C for up to 72 h
of serial twofold dilutions of garlic substances in 5 ml of broth
in 16-ml test tubes (for Campylobacter spp., 2-ml broth in
bijoux bottles). MIC determinations were carried out in trip-
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licate, and consistent values were obtained for each bacterial
isolate. Killing effects were confirmed by plating out onto TSA.
For a range of gram-positive and gram-negative enteric bac-
teria, including food-borne pathogens, MICs (Table 1) ob-
tained for GO and GP indicated growth inhibition of all the
bacteria tested. Incubation of MIC tubes for 48 h gave either
the same or around twofold the 24-h MICs.
MICs varied widely (0.02 to 5.5 mg/ml) between different
species and mostly within a 10-fold GO concentration range
for different isolates of the same species. No obvious differ-
ences between the sensitivities of clinical and culture collection
enteric isolates were observed. MICs for species commonly
associated with food poisoning were similar to those observed
for commensals, although with GO the latter tended to greater
sensitivity than pathogens. However, with the human enteric
pathogens Campylobacter spp., Listeria monocytogenes, and
Vibrio parahaemolyticus and one clinical isolate of Yersinia en-
terocolitica, sensitivities to GO were many times greater than
for the commensals L. acidophilus and E. coli.
Time course viability studies were carried out to reveal the
effects of GO upon cell growth and viability. Serial twofold
dilutions of GO or component sulfides, were prepared in 50-ml
boiling tubes with TSB, sterile distilled water (SDW), or min-
imal salts medium (MSM) (composition of which [each value
in grams/liter] was KH2PO4, 1.0; K2HPO4, 1.0; KNO3, 1.0;
(NH4)2SO4, 1.0; MgSO4z7H2O, 0.1; NaCl, 0.1), producing final
volumes of 20 ml. The tubes were inoculated with 40 ml of an
overnight culture of E. aerogenes, producing initial viable cell
populations of 106 CFU/ml, capped with aluminum foil, and
incubated aerobically at 37°C for 24 h. Periodically, tubes were
aspirated to homogenize the culture, and then 0.5-ml samples
were removed for viable count determinations. Exposure to
GO (Fig. 1A) and GP (Fig. 1B) of E. aerogenes grown in TSB
revealed concentration-dependent capacities to kill or inhibit
population growth. This pattern of effect replicates that of
other time studies that we have performed upon other micro-
organisms with garlic components (reference 15 and unpub-
lished observations).
With GO, an initial lag phase of 30 to 60 min occurred at
concentrations of 0.34 to 2.75 mg/ml. Longer lag phases were
observed with GP and were greater at lower concentrations
(e.g., lag phases with GO were 30 min for 50 mg/ml and 400
min for 6.25 mg/ml). Lag phases may reflect delay in uptake of
garlic molecules and/or of toxic effect upon metabolic pro-
TABLE 1. MIC determinations of GO and GP against human enteric pathogens and commensalsa
Bacterium
GO assay GP assay
No. of strains
tested
MIC (mg/ml) No. of strains
tested
MIC (mg/ml)
24 h 48 h 24 h 48 h
Human enteric pathogens
Bacillus cereus 1 0.08 0.17
Escherichia coli O55 1 5.5 5.5 1 12.5 25
Escherichia coli O128 1 2.75 2.75 1 12.5 25
Escherichia coli O112 1 2.75 5.5 1 3.13 3.13
Shigella boydiib 1 1.37 2.75 1 6.25 6.25
Shigella flexnerib 1 1.37 2.75 1 6.25 6.25
Shigella sonneib 4 2.75 2.75–5.5 3 12.5 12.5
Vibrio fluvialisb 1 2.75 2.75
Vibrio metschnikoviib 1 0.02 0.34
Vibrio parahaemolyticusb 1 0.04 0.08
Yersinia enterocoliticab 3 0.17–0.34 0.68 2 6.25 6.25
Listeria monocytogenesb 2 0.02 0.02–0.08 2 6.25 25
Salmonella enterica serovar Enteritidisb 2 5.5 5.5 3 6.25 12.5–25
Salmonella enterica serovar Infantisb 1 2.75 5.5 1 6.25 25
Salmonella enterica serovar Senftenbergb 2 5.5 5.5 1 12.5 25
Salmonella enterica serovar Typhimuriumb 3 0.34–2.75 0.68–5.5 3 6.25–12.5 12.5–25
Campylobacter jejuni 4 0.16–0.32c 0.16–0.32d 4 3.13–12.5c 3.13–25d
Campylobacter coli 1 0.16c 0.49d 1 3.13c 6.25d
Campylobacter lari 1 0.16c 0.49d 1 1.59–3.13c 3.13d
Commensal enteric bacteria
Bacteroides fragilis 2 0.02–0.04 0.04 1 6.25 6.25
Bacillus subtilus 3 0.17 0.17–0.68
Enterobacter aerogenes 1 0.68 0.68 1 6.25 6.25
Enterococcus faecalisb 1 0.34 0.34
Escherichia coli 13 0.34–2.75 0.34–5.5 4 3.13–12.5 6.25–25
Klebsiella aerogenes 1 0.04 0.17 1 12.5 12.5
Proteus vulgaris 1 1.37 2.74
Lactobacillus acidophilus 5 0.17–2.75 0.34–2.75 2 6.25 12.5
Streptococcus faecalisb 2 0.34 0.34
Streptococcus mutans 1 0.08 0.08
Streptococcus pyogenes 1 0.02 0.04
a Each MIC determination was performed in triplicate per bacterial isolate. Range values refer to MICs determined for the different enteric isolates tested.
b Enteric isolates.
c MICs were determined at 48 h.
d MICs were determined at 72 h.
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cesses. However, at the higher concentrations used (5.5 to 22
mg/ml), and at lower concentrations in nutrient-deficient me-
dia (Fig. 1C), a potential for rapid bactericidal action of GO
was indicated by complete loss of viability during the first 2 h.
Comparable bactericidal effects were observed with GP con-
centrations of 6.25 to 50 mg/ml. At concentrations of 0.34 to
1.375 mg/ml, declines in viability were temporary and recovery
of growth occurred. The latter ensued after shorter delays, at
higher rates, and to greater levels the lower the GO concen-
tration. This recovery of viability was not observed with GP.
At the intermediate GO concentration of 2.75 mg/ml, via-
bility declined during the first 5 to 6 h and then levelled out,
and HPLC analysis at this concentration showed that GO sul-
fide loss was greatest over this initial period when sampling-
related agitation was greatest. Losses over 24 h were greatest
for the smaller, lower-boiling-point sulfides (ca. 75% for DMT,
60% for DAS, 40% for DADS, and 20% for DATS and
DATTS). Thus, volatilization is the most plausible explanation
for these losses and could explain the recovery of E. aerogenes
viability observed at concentrations of 0.34 to 2.75 mg of GO/
ml. It could also explain why MICs were frequently higher at
48 h than at 24 h and why the MIC for E. aerogenes obtained
in time studies was 2.75 mg/ml—considerably higher than the
0.68-mg/ml concentration obtained under static capped-tube
conditions. With GP, the bactericidal concentration of 6.25
mg/ml obtained from the MIC study corresponded to that
obtained in the time study, in which little evidence for recovery
of viability was observed. This greater consistency of result
probably results from the lesser volatility of the thiosulfinates
of GP.
The time course study (Fig. 1C) of different microbial media
indicates that medium composition is an important factor in-
fluencing antimicrobial activity of GO. Thus, at 2.75 mg of
GO/ml, complete killing occurred within a few hours in each of
SDW, MSM, and MSM plus glucose. In contrast, at the same
GO concentration in TSB, after a steep initial drop, leveling-
off of viability occurred, as was previously observed (Fig. 1A).
The role of tryptone in explaining this apparent protective
effect of TSB was supported by positive correlation of E. aero-
genes viability with levels of tryptone ranging from 0 to 15
g/liter of MSM (data not shown) in the presence of the poten-
tially bactericidal concentration of 2.75 mg of GO/ml. Cysteine
produced a similar effect as was shown by partial neutralization
of the bactericidal effects of 2.75 mg of GO/ml in MSM in the
presence of 10 mM cysteine and very substantial neutralization
in the presence of 25 mM cysteine. As TSB and tryptones are
likely sources of cysteine, protein components of other micro-
bial growth matrices may produce similar reductions in anti-
microbial effects of GP and GO. This means that the results of
our own and previous studies of garlic materials may represent
underestimates of their full antimicrobial potential.
MICs obtained for DMT and DASS were species dependent
for a range of GO-sensitive bacteria (Table 2). The species
most sensitive to GO were also those most sensitive to DMT
and DASS (L. monocytogenes, Y. enterocolitica). For all five
species tested, sensitivity to DMT was severalfold greater than
that to DASS and similar or slightly greater to DMT than to
FIG. 1. (A) The effect of GO upon E. aerogenes viability with time.
n , 0 mg/ml (control); F, 0.34 mg/ml; }, 0.68 mg/ml; , 1.38 mg/ml; 3,
2.75 mg/ml; h, 5.5 mg/ml; E, 11 mg/ml; , 22 mg/ml. (B) The effect of
GP upon E. aerogenes viability with time. n , 0 mg/ml (control); F, 3.13
mg/ml; }, 6.25 mg/ml, , 12.5 mg/ml; 3, 25 mg/ml; h, 50 mg/ml. (C)
The effect of a 2.75-mg/ml GO concentration upon E. aerogenes in
SDW and MSM with and without a carbon source (glucose). n , TSB;
h, TSB 1 GO; }, SDW; {, SDW 1 GO; , MSM; , MSM 1 GO;
F, MSM 1 1.0% glucose; E, MSM 1 1% glucose 1 GO.
TABLE 2. Mean 24-h MICs of a selection of GO sulfides
against six enteric bacteria
Enteric isolate
MIC (mg/ml)
GO DASS DMT
E. aerogenes 0.68 25 0.31
E. coli 0.68 25 0.31
S. enterica serovar Typhimurium 0.34 25 0.31
S. sonnei 2.75 10 0.02
L. monocytogenes 0.02 0.63 0.04
Y. enterocolytica 0.02 0.63
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GO. These similarities of ratio between MICs of DASS and
DMT for each bacterium suggest a common antibacterial
mode of action for GO sulfides.
The antimicrobial potency of DASS indicates that the major
(i.e., diallyl) sulfide constituents of GO contribute significantly
to the antimicrobial activity of GO. However, DASS exhibited
MICs substantially higher than those of GO for all species
tested so that diallyl sulfides do not fully explain GO activity.
This result is consistent with the lower antimicrobial activities
observed for diallyl sulfides separately when compared with
GO (15, 17). These differences have been proposed to result
from the synergistic activities (17, 18) of GO sulfides. However,
our finding that DMT possesses high antimicrobial activity,
and evidence that the antimicrobial potency of diallyl sulfides
increases with each additional S atom (15, 17), raises the pos-
sibility of methyl sulfides and/or higher polysulfides explaining
the high relative antimicrobial activity of GO.
As the considerable antimicrobial activity of GO and its
sulfide constituents, several of which possess sulfhydryl (SH)
reactivity (2, 21), was reduced in the presence of SH groups, an
SH-reactive mode of action like that proposed for allicin is
suggested. The greater reactivity of allicin (13) than GO sul-
fides with cysteine is associated with its sulfur-bound oxygen
atom (17) and could explain its stronger antimicrobial effect
(15, 17).
The actions of GP reported here against a number of enteric
bacteria are consistent with broad-spectrum antibacterial ef-
fects previously evidenced (17) for aqueous garlic bulb ex-
tracts. The MIC results for GP over 24 h (Table 1) were
comparable to those reported earlier (16).
The potency of GO was substantially greater than that of GP
(Table 3) on a weight-of-garlic-product basis. However, when
allowing for the dilution of alliin within the GP matrix and the
consequent yield of allicin plus other thiosulfinates (1.6% of
GP), the reverse was true for all species tested excepting for
those most sensitive to GO (L. monocytogenes, B. fragilis).
Thus, early findings (5) that the active constituents (i.e., allicin
and other thiosulfinates) of garlic bulb extracts such as GP
solution yield substantially greater antimicrobial activity than
GO were confirmed. However, contrary to the early studies
(5), which were negative for GO, our findings indicate that GO
possesses substantial and broad-spectrum antibacterial activity
against both gram-positive and -negative bacteria. For some
isolates (Vibrio metschnikovii and L. monocytogenes), sensitivity
to GO was as high as that recently reported for H. pylori (15).
The far greater potency of GO on a unit weight of product
basis reflects the much greater concentration of antibacterial
substances present in GO than in water-soluble garlic bulb
extracts such as GP. Whereas GP requires solubilization in a
suitable aqueous medium (this excludes acidic gastric juice), so
as to enable the enzyme-catalyzed formation of its active thio-
sulfinate components, the active components of GO are al-
ready present. Moreover, the observed reduction in the anti-
microbial effect of GO by protein digestion products and
cysteine, which are abundant in the gut, would probably be
greater for GP-derived allicin, because of its higher cysteine
affinity (13). These differences suggest that GO might have
greater clinical potential than GP despite the usually greater
antimicrobial potency of the latter. The potential of GO to
combat human gut infection is supported by our initial obser-
vations of its significant antimicrobial effects within ex vivo
samples of human digesta (data not shown).
In conclusion, the results suggest that earlier evaluation of
the antimicrobial activity of GO sulfides using agar plate meth-
ods (5), which indicated negligible antimicrobial activity, failed
to take account of the hydrophobic and volatile nature of GO.
In contrast, our results show that GO exhibits considerable
antimicrobial activity when tested in liquid cultures, especially
when precautions to minimize volatilization loss are applied.
Reduced antimicrobial activity in the presence of tryptone and
cysteine suggests that GO activity may be underestimated in
microbial culture media and reduced within the enteric envi-
ronment and is compatible with evidence that the mode of
action of garlic compounds depends upon SH reactions.
Both GO and GP revealed wide-spectrum antimicrobial ac-
tivities. Molecule for molecule, these activities were greater
with GP thiosulfinates than GO sulfides against most bacteria
tested. However, the antibacterial activities of GO and GO
sulfides were substantial against several pathogenic species,
some of which are significant causes of food poisoning, so that
further exploration of the potential of GO in enteric disease
control is warranted.
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